PHARMACEUTICAL FORMULATION CONTAINING SODIUM PALMITOYL-L-PROLYL-L-PROLYL-GLYCYL-L-TYROSINE AND METHOD FOR MANUFACTURING SAME

摘要

The present invention relates to a pharmaceutical formulation having excellent bioavailability and stability, and containing sodium palmitoyl-L-prolyl-L-prolyl-glycyl-L-tyrosine (compound I) as an active component. The pharmaceutical formulation according to the present invention can be usefully used as a formulation for treating inflammatory bowel diseases, etc., since the active component compound I is not decomposed in the stomach and is released from the intestine.;COPYRIGHT KIPO 2020